Twinship and risk of postmenopausal breast cancer

被引:41
|
作者
Cerhan, JR
Kushi, LH
Olson, JE
Rich, SS
Zheng, W
Folsom, AR
Sellers, TA
机构
[1] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[3] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA
[4] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29208 USA
关键词
D O I
10.1093/jnci/92.3.261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Intrauterine exposure to high levels of endogenous estrogens has been hypothesized to:increase the risk of breast cancer. Because estrogens and other pregnancy hormones are substantially elevated in twin pregnancies, and possibly more so in dizygotic twin pregnancies, we evaluated the association between aspects of twin membership (i.e., belonging to a twin pair) and the risk of breast cancer. Methods: In a cohort of 29 197 postmenopausal Iowa women with no prior diagnosis of cancer (except for nonmelanoma skin cancer), breast cancer risk factors were determined by use of a mailed questionnaire in 1986 (baseline); twin membership, sex of the twin, and zygosity were determined by use of a follow-up questionnaire in 1992, Results: Within the cohort, 1.8% (n = 538) of the women reported being a twin; of these, 24% (n = 130) were monozygotic twins, 63% (n = 337) were dizygotic twins, and 13% (n = 71) did not-know their zygosity, From 1986 through 1996, 1230 breast cancers in the cohort were ascertained by linkage to the Iowa Cancer Registry. Compared with singletons, women who belonged to a twin pair were at elevated risk of breast cancer (multivariate-adjusted risk ratio [RR] = 1.72; 95% confidence interval [CI] = 1.22-2.42), with adjustment for educational level, family history of breast cancer, height, body mass index, body fat distribution, age at menarche, age at first live birth, use of hormone replacement therapy, and alcohol use. Multivariate-adjusted risk was elevated (in comparison with singletons) if the sex of the other twin was female (RR = 1.82; 95% CI = 1.20-2.75); however, this risk was limited to female dizygotic twins (RR = 2.14; 95% CI = 1.21-3.79), since no excess risk was evident for monozygotic twins (RR = 1.04; 95% CI = 0.43-2.50), The risk to women with a male twin was also elevated (RR = 1.49; 95% CI = 0.80-2.78) in comparison with singletons, but this estimate was not statistically significant, Conclusions: This cohort study lends further support to the theory that there are important intrauterine influences on carcinogenesis of the breast.
引用
收藏
页码:261 / 265
页数:5
相关论文
共 50 条
  • [1] Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
    Rennert, G.
    Pinchev, M.
    Rennert, H. S.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 490S - 490S
  • [2] Urinary phytoestrogens and postmenopausal breast cancer risk
    den Tonkelaar, I
    Keinan-Boker, L
    Van't Veer, P
    Arts, CJM
    Adlercreutz, H
    Thijssen, JHH
    Peeters, PHM
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (03) : 223 - 228
  • [3] Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
    Rennert, Gad
    Pinchev, Mila
    Rennert, Hedy S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3577 - 3581
  • [4] Phthalate Metabolites and Postmenopausal Breast Cancer Risk
    Reeves, K. W.
    Santana, Diaz M.
    Hankinson, S. E.
    Bigelow, C.
    Zoeller, R. T.
    Manson, J.
    Spiegelman, D.
    Tinker, L.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (03) : 355 - 355
  • [5] Dietary patterns and the risk of postmenopausal breast cancer
    Fung, TT
    Hu, FB
    Holmes, MD
    Rosner, BA
    Hunter, DJ
    Colditz, GA
    Willett, WC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (01) : 116 - 121
  • [6] Obesity and the Risk for Premenopausal and Postmenopausal Breast Cancer
    Anderson, Garnet L.
    Neuhouser, Marian L.
    [J]. CANCER PREVENTION RESEARCH, 2012, 5 (04) : 515 - 521
  • [7] Postmenopausal testosterone therapy and breast cancer risk
    Somboonporn, W
    Davis, SR
    [J]. MATURITAS, 2004, 49 (04) : 267 - 275
  • [8] Fracture risk with tamoxifen in postmenopausal breast cancer
    Short, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 4 - 4
  • [9] Postmenopausal hormone therapy and the risk of breast cancer
    Speroff, L
    [J]. MATURITAS, 1999, 32 (03) : 123 - 129
  • [10] Breast cancer risk with postmenopausal hormonal treatment
    Collins, JA
    Blake, JM
    Crosignani, PG
    [J]. HUMAN REPRODUCTION UPDATE, 2005, 11 (06) : 545 - 560